By Jeffrey T. Lewis
Biotricity Inc.’s shares rose 7.7% to $4.34 after the medical technology company said it completed a $12-million non-convertible debt financing process.
The Redwood City, Calif.-based company’s shares started this year at 74 cents, and closed at a more than three-year high of $4.67 on Dec. 13.
Biotricity said it received the $12-million cash infusion from SWK Funding LLC, an investor in healthcare and life sciences companies, and that the money will be used to replace debt that is coming due, support inventory and finance annual recurring revenue subscriptions.
Write to Jeffrey T. Lewis at firstname.lastname@example.org
(END) Dow Jones Newswires
December 27, 2021 11:32 ET (16:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.